Healthcare provider profile · identity verified

Seth Lowell Thomas, DO

Family Practice · CLINTON, NC · NPI 1518522986

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	323	82
Omeprazole	Omeprazole	245	60
Amlodipine Besylate	Amlodipine Besylate	235	62
Gabapentin	Gabapentin	226	50
Prednisone	Prednisone	198	133
Hydrochlorothiazide	Hydrochlorothiazide	180	49
Levothyroxine Sodium	Levothyroxine Sodium	178	45
Furosemide	Furosemide	174	55
Albuterol Sulfate Hfa	Albuterol Sulfate	163	62
Losartan Potassium	Losartan Potassium	156	45
Metformin Hcl	Metformin Hcl	152	40
Montelukast Sodium	Montelukast Sodium	140	38
Duloxetine Hcl	Duloxetine Hcl	136	37
Metoprolol Succinate	Metoprolol Succinate	134	39
Carvedilol	Carvedilol	123	29
Pantoprazole Sodium	Pantoprazole Sodium	121	39
Pravastatin Sodium	Pravastatin Sodium	112	29
Lisinopril	Lisinopril	111	32
Potassium Chloride	Potassium Chloride	106	30
Alprazolam	Alprazolam	105	25
Ozempic	Semaglutide	101	18
Tramadol Hcl	Tramadol Hcl	93	26
Olmesartan Medoxomil	Olmesartan Medoxomil	91	24
Rosuvastatin Calcium	Rosuvastatin Calcium	87	31
Trazodone Hcl	Trazodone Hcl	87	26
Metoprolol Tartrate	Metoprolol Tartrate	86	27
Tamsulosin Hcl	Tamsulosin Hcl	79	17
Eliquis	Apixaban	78	19
Fluticasone Propionate	Fluticasone Propionate	76	35
Meloxicam	Meloxicam	76	28
Zolpidem Tartrate	Zolpidem Tartrate	75	suppressed
Hydralazine Hcl	Hydralazine Hcl	68	17
Escitalopram Oxalate	Escitalopram Oxalate	67	16
Jardiance	Empagliflozin	67	14
Metformin Hcl Er	Metformin Hcl	66	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	28
Glipizide Er	Glipizide	62	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	16
Sertraline Hcl	Sertraline Hcl	61	20
Enalapril Maleate	Enalapril Maleate	60	14
Pregabalin	Pregabalin	58	15
Allopurinol	Allopurinol	56	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	56	12
Clopidogrel	Clopidogrel Bisulfate	54	18
Simvastatin	Simvastatin	54	13
Spironolactone	Spironolactone	53	15
Lorazepam	Lorazepam	52	suppressed
Famotidine	Famotidine	51	16
Paroxetine Hcl	Paroxetine Hcl	51	14
Azithromycin	Azithromycin	50	43
Cephalexin	Cephalexin	49	39
Bupropion Xl	Bupropion Hcl	48	suppressed
Ondansetron Hcl	Ondansetron Hcl	45	13
Ezetimibe	Ezetimibe	43	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	42	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	41	18
Mirtazapine	Mirtazapine	41	11
Baclofen	Baclofen	39	11
Doxycycline Monohydrate	Doxycycline Monohydrate	39	30
Fluconazole	Fluconazole	38	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	13
Amoxicillin	Amoxicillin	35	34
Glipizide	Glipizide	35	13
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	33	suppressed
Azelastine Hcl	Azelastine Hcl	31	22
Clonazepam	Clonazepam	29	suppressed
Donepezil Hcl	Donepezil Hcl	29	suppressed
Eszopiclone	Eszopiclone	28	suppressed
Metolazone	Metolazone	28	11
Triamcinolone Acetonide	Triamcinolone Acetonide	28	20
Colchicine	Colchicine	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Glimepiride	Glimepiride	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	13
Finasteride	Finasteride	24	suppressed
Topiramate	Topiramate	24	suppressed
Verapamil Er	Verapamil Hcl	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Mupirocin	Mupirocin	22	18
Ibuprofen	Ibuprofen	21	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Levofloxacin	Levofloxacin	18	15
Primidone	Primidone	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Clonidine	Clonidine	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Naproxen	Naproxen	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	12
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Selenium Sulfide	Selenium Sulfide	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error